Philippine News Agency
PH ready to participate in clinical trials of Avigan: Duterte
The Philippines has confirmed its readiness to join clinical trials for Avigan, a Japanese anti-influenza drug being explored as a potential treatment for the coronavirus.
President Rodrigo Duterte announced the country's participation during a special ASEAN Plus Three Summit on COVID-19.
Avigan, also known as Favipiravir, is manufactured by a subsidiary of Fujifilm Holdings Corp.
Researches in China have revealed that the drug is seen as effective in treating COVID-19.
Japan has begun conducting clinical tests to examine the effectiveness and safety of Avigan.
The Japanese government plans to offer Avigan for free to nations hit by the COVID-19 pandemic.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
